Sinocelltech(SH:688520) Xin Lang Zheng Quan·2025-10-20 02:40Group 1 - The core viewpoint of the news is that Shenzhou Cell has experienced fluctuations in its stock price and trading volume, with a notable increase of 48.91% year-to-date, but a decline of 36.49% over the past 60 days [1] - As of October 20, Shenzhou Cell's stock price was 53.95 CNY per share, with a market capitalization of 24.026 billion CNY and a trading volume of 86.5076 million CNY [1] - The company has seen net outflows of main funds amounting to 595,100 CNY, with significant buying and selling activity from large orders [1] Group 2 - Shenzhou Cell operates in the biopharmaceutical sector, focusing on the research and commercialization of biological drugs for various diseases, including cancer and autoimmune diseases [2] - For the first half of 2025, Shenzhou Cell reported a revenue of 972 million CNY, a year-on-year decrease of 25.50%, and a net profit attributable to shareholders of -33.7711 million CNY, a decline of 126.87% [2] - The number of shareholders decreased by 12.74% to 9,754, while the average circulating shares per person increased by 14.60% to 45,656 shares [2]